Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. - Wikidata - awgldk - TriplyDB

Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

http://www.wikidata.org/entity/Q33978656

about

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Postmortem brain: an underutilized substrate for studying severe mental illness Cross-diagnostic comparison of duration mismatch negativity and P3a in bipolar disorder and schizophrenia.Acute D-serine treatment produces antidepressant-like effects in rodents Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorder.Bimodal effect of lithium plasma levels on hippocampal glutamate concentrations in bipolar II depression: a pilot study.Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients.N-methyl-D-aspartate receptor expression in parvalbumin-containing inhibitory neurons in the prefrontal cortex in bipolar disorder Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder.Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.Integrated neurobiology of bipolar disorder.Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects GluN2B protein deficits in the left, but not the right, hippocampus in schizophrenia.Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis.Glutamatergic modulators: the future of treating mood disorders?Differential roles of hippocampal glutamatergic receptors in neuropathic anxiety-like behavior after partial sciatic nerve ligation in rats.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder The N-methyl-D-aspartate receptor as a neurobiological intersection between bipolar disorder and alcohol use: a longitudinal mismatch negativity study Novel glutamatergic agents for major depressive disorder and bipolar disorder.Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Transcription factor SP4 phosphorylation is altered in the postmortem cerebellum of bipolar disorder and schizophrenia subjects Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain Overview of Glutamatergic Dysregulation in Central Pathologies.NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia Cholinergic connectivity: it's implications for psychiatric disorders.Chronic administration of valproic acid reduces brain NMDA signaling via arachidonic acid in unanesthetized rats.Neurotransmission and bipolar disorder: a systematic family-based association study.Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder.Molecular evidence of synaptic pathology in the CA1 region in schizophrenia.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes.Neuropathology of mood disorders: do we see the stigmata of inflammation?

P2860

Q24629398-07A80D32-EAB6-4D83-85BA-6FFE621352E1 Q24630153-B6369483-C427-48E2-ADA6-73D930409E34 Q30422050-0E47FC15-DFF1-401F-B7B9-959129F11073 Q30454920-D4108686-A19D-4300-9E05-462AD0AB35C6 Q30505292-756D8E55-C499-4732-8DA7-EEF349E8ECF3 Q30713152-1A8BC9E2-07B2-4CA9-A4F4-91ACC721114B Q30880781-3D2D55C9-A071-42C7-AAD6-CC3C9F5AB438 Q33751063-3EA3CEDE-FE3D-4703-80A0-45B0E65F8ED9 Q33796465-FC9CDF18-FCC5-4EB9-BE83-A00E90204163 Q33838237-9CC523DB-C105-4D65-BBDC-C43EE093D84C Q33891806-50A831C4-5DE3-453A-AD90-BA275CC4C53B Q34080310-A288BA36-6BE1-478F-AB1E-27F5CDE1B387 Q34204211-05228672-95F3-48C5-9C38-2FF151CF8466 Q34254887-1A39C4F8-C530-43DE-A7C4-3A0473064628 Q34332929-C7683522-756F-42B8-97EF-D09EFBD6B742 Q34352492-EBBDA515-4048-45E5-B6BD-265B6A4F8191 Q34398007-68480E6F-C324-444B-B980-769E94B2CAC4 Q35213544-1F612B1B-38CD-4C4C-8C82-50AF6EDBD883 Q35476477-7C243487-6D94-4721-91B1-5B97AE4EED8D Q35626959-1AD69ACD-5CCD-4BF8-A545-0D7AF03FFD19 Q35661119-1B2ABD75-3357-4A38-9A08-85BBBBD356E7 Q35661134-B7312A0B-E90C-414F-BE2B-08D1B1CCD5B8 Q35687971-BB393296-9182-4B87-8F2E-BF4012E143F3 Q35742545-140C7FE3-FE42-499B-925F-70E545D71B5B Q36145508-E6F9ED39-51F7-417E-B471-DC0A732345B4 Q36253556-688E09FC-939D-41D2-B486-BE9943629952 Q36409596-25EC6071-30E9-4B40-A97E-2D3E5E2D1BA4 Q36718684-80C6ABD5-5E20-4F4B-9B30-DF62C264C4DF Q36812599-5FA5B326-21D1-4E2E-9F50-777A5732D9C4 Q36930683-82679676-2EF9-453B-B71A-03F0A9F14B24 Q36952439-FA32682A-B196-4FEF-AB71-6751EEB29FF3 Q37069416-E551F01A-15C1-4319-A8ED-7C0C01F5877D Q37094982-B78F1E1F-02C3-4969-AA86-65CE75645BDB Q37143117-C7CC274A-3A20-4D22-880C-8E0F99CB0DE2 Q37387700-36FB850B-8DE4-4BAE-A4D9-26D47F75DE8E Q37481603-16D5E2FD-D9A3-470C-9A78-2BC195D02A66 Q37590122-0BC1220C-9A98-4B9B-96FD-3F8EAC3EE615 Q37629424-23F93553-CC9B-4032-B909-01278CBB0F3F Q37634525-1488F0AF-F138-4A21-AA96-571892FD6B33 Q37648274-87D39514-5C4A-4AE1-AC09-5DE8A58D5C11

P2860

Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder.

http://www.wikidata.org/entity/Q33978656

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@ast

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@en

type

label

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@ast

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@en

prefLabel

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@ast

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@en

P1433

Q33978656-1C0F6CB8-16D8-451F-8367-AFC18C89D19E

P1476

Q33978656-17843432-4794-4F9D-9637-70CDCFA97A8B

P2093

Q33978656-2214DEBB-499B-42B8-B996-CB398C213D3E

Q33978656-42EB54B8-FC58-4987-8D1D-2AF9A776579B

Q33978656-7B5F1BD6-AFD4-4F01-844A-7F1DED7EFCD4

Q33978656-9213D91F-D3F3-471A-A036-274229DF6B1D

Q33978656-9C87229A-8D3A-4AAF-97F2-C7DE8B39A594

Q33978656-C40191E6-11FE-4251-B393-D33F861B4008

P2860

Q33978656-01479FF1-0B4F-4F43-BEE6-65644E7782BD

Q33978656-03680D75-1DBD-42BA-8D7D-61D301E2D41E

Q33978656-07D792AD-8805-4771-B8CE-577D7E23F9BC

Q33978656-14400CED-0AF8-44A3-898F-01A7FB5BDACB

Q33978656-16BF5BC7-2010-4873-B320-A3612FD6AEFD

Q33978656-17095FAF-9E7D-4440-B166-E313EB87E3F0

Q33978656-26208E08-6C9B-4084-B04D-EB9E6D7DD98E

Q33978656-279514D2-68BE-4ED9-B7C4-90057803793A

Q33978656-2BA0FC52-47FF-4B9D-B589-6AC8A6B67690

Q33978656-322679DC-4B54-4B5D-85A7-E41DB3D7A6E9

P304

Q33978656-C53F5E79-3AFD-4C7D-ABC6-8FB3B70F7E04

P31

Q33978656-82063058-736C-4F24-8383-4F73580261ED

P356

Q33978656-9DF09F2A-3CAB-49E6-9485-C45A203DE3E0

P407

Q33978656-4D043240-A0CD-4EAC-9E8D-925C99399900

P433

Q33978656-C9EFAF95-4172-4603-9CD9-84A68504CD28

P478

Q33978656-0325F1D2-2015-4266-9BAD-24077A57BB2A

P577

Q33978656-E89A8056-121E-4EA6-927A-ABC16DCCAC49

P5875

Q33978656-5E96664A-2ECA-48DB-A65A-846B43C6659E

P698

Q33978656-3CE2F71A-F836-4F45-AE0C-A9663030B87A

P921

Q33978656-66D2EFFC-1C71-467E-A91E-FEEEEF777DA3

P932

Q33978656-E54ABB0A-5EE2-4BF6-B542-7C6D207D59D0

P356

J.BRAINRES.2006.09.011

P1433

P1476

Decreased NR1, NR2A, and SAP10 ...... ppocampus in bipolar disorder.

@en

P2093

Brian Dean

http://www.w3.org/2001/XMLSchema#string

Elizabeth Scarr

http://www.w3.org/2001/XMLSchema#string

James H Meador-Woodruff

http://www.w3.org/2001/XMLSchema#string

Lars V Kristiansen

http://www.w3.org/2001/XMLSchema#string

Monica Beneyto

http://www.w3.org/2001/XMLSchema#string

Robert E McCullumsmith

http://www.w3.org/2001/XMLSchema#string

P2860

Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102

The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates

Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons.

NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex

Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics

Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia

Long-term potentiation--a decade of progress?

Cloned glutamate receptors

Probing the human hippocampus using rCBF: contrasts in schizophrenia.

Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia.

P304

108-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BRAINRES.2006.09.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1127

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6684890

http://www.w3.org/2001/XMLSchema#string

P698

17113057

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

2900828

http://www.w3.org/2001/XMLSchema#string